MeiraGTx Holdings (MGTX) Tax Provisions (2018 - 2019)
MeiraGTx Holdings (MGTX) posted Tax Provisions of $3.5 million for Q4 2019, up 1133.18% on a QoQ basis from -$338670.0 in Q3 2019, and up 837.59% year-over-year from $373197.3 in Q4 2018.
MeiraGTx Holdings (MGTX) Tax Provisions (2018 - 2019) Analysis & Trends
MeiraGTx Holdings' Tax Provisions history runs 2 years deep, the most recent figure standing at $3.5 million for Q4 2019.
- Quarterly Tax Provisions rose 837.59% year-over-year to $3.5 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $2.6 million (changed N/A YoY) and the FY2019 annual result came in at $3.1 million, up 746.93% from the prior year.
- Tax Provisions was $3.5 million for Q4 2019 at MeiraGTx Holdings, up from -$338670.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $3.5 million in Q4 2019 and bottomed at -$474391.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 3.50 Mn |
| Sep 30, 2019 | -338,670.00 |
| Jun 30, 2019 | -91,390.00 |
| Dec 31, 2018 | -474,391.00 |